Abstract Details

Title Time Course of Glatiramer Acetate Efficacy in Relapsing-Remitting Multiple Sclerosis Patients in the Glatiramer Acetate Low-Frequency Administration (GALA) Study

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mat D. Davis PRESENTER	Mat D. Davis has received personal compensation for serving as an employee of Teva pharmaceuticals. Mat D. Davis has received stock or an ownership interest from Teva Pharmaceuticals.
	No disclosure on file
	No disclosure on file
Volker A. Knappertz, MD (Lacum Neurology)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��